arznei-telegramm Logo a-t Kurzlogo
    ❮ a-t 11/2020 a-t ❯
    This is a translation of the table of contents. One article of each issue is translated and freely available.
    table of contents
    NEW ON THE MARKET

    High-dose influenza vaccine (FLUZONE HIGH-DOSE QUADRIVALENT) for elderly?

    Filgotinib (JESELECA) for rheumatoid arthritis

    Ibalizumab (TROGARZO) for multi-resistant HIV infection (short version)

    THERAPY FROM A CRITICAL VIEWPOINT

    Vitamin D against COVID-19?
    free

    a-t READERS QUESTIONS AND COMMENTS

    Proper diagnosis is necessary before use of prescription-free treatments for irritable bowel syndrome

    BEWARE MISINFORMATION

    NEURASAN: becoming a non-smoker with a success rate of 90%?

    CURRENT ADR NETWORK REPORT

    Hypernatraemia and polyuria with the narcotic gas sevoflurane

    SIDE EFFECTS

    Progressive multifocal leukoencephalopathy with dimethyl fumarate (TECFIDERA) also in the setting of mild lymphopenia

    Dimethyl fumarate (e.g. TECFIDERA) and alopecia

    Fingolimod (GILENYA): liver failure, varicella zoster encephalitis and other adverse events

    Heart valve insufficiency with fluoroquinolones

    Xylomethazoline nasal drops 0.025% no longer for babies

    e a-t ON THE INTERNET

    Ibalizumab (TROGARZO) for multidrug-resistant HIV infection (long version)

    arznei-telegramm

    Independent drug information – in English

    Concise, critical evaluations of drugs and medical devices for evidence-based therapy and patient advice on benefits and risks – independent, ad-free and funded exclusively by subscriptions.

    Browse free articles

    Wir schätzen Ihr Feedback

    Nehmen Sie an unserer Umfrage teil!